MedTrace Logo

Russian Prospective Multicenter Registry Study of Intravenous Thrombolytic Therapy for Acute Ischemic Stroke

NCT04674293 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2020-12-19

No results posted yet for this study

Summary

Russian prospective multicenter registry study of intravenous thrombolytic therapy for acute ischemic stroke.

Conditions

  • The Aim the Study is to Collect and Analyze Data on Patients With Acute Ischemic Stroke During Intravenous Thrombolytic Therapy With Alteplase

Interventions

DRUG

Revelisa

Thrombolytic therapy for patients with ischemic stroke

Sponsors & Collaborators

  • Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2020-12-01
Completion
2022-01-01

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04674293 on ClinicalTrials.gov